First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

Abstract

The combination chemotherapy of irinotecan and capecitabine is an active and tolerable regimen for advanced colorectal adenocarcinoma, but the observed deaths suggest a future randomized trial that requires a cautious patient selection.